// App-Quantinova.ai

2534 : NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Researchers

Presenter

  • Il-Kwon Lee

Principal Investigators

  • Dennis Dong Hwan Kim

  • Namshin Kim

  • Yun Gyeong Lee

  • Sung-Hoon Jung

  • Je-Jung Lee

  • Hyeoung-Joon Kim

  • Chul Won Jung

  • Jun-Ho Jang

  • Hee Je Kim

  • Joon Ho Moon

  • Sang Kyun Sohn

  • Jong-Ho Won

  • Sung-Hyun Kim

  • Jungwon Huh

Medical Centers

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Nucleophosmin 1

  • Fms related tyrosine kinase 3

  • GTPase Nras

  • Isocitrate dehydrogenase 1

  • Isocitrate dehydrogenase 2

  • Tet methylcytosine dioxygenase 2

  • WT1 Transcription Factor

  • Splicing Factor 3b Subunit 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved